These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32027707)

  • 61. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
    Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
    Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Contributions of phosphorylation to regulation of OCTN2 uptake of carnitine are minimal in BeWo cells.
    Rytting E; Audus KL
    Biochem Pharmacol; 2008 Feb; 75(3):745-51. PubMed ID: 17977516
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha.
    Maeda T; Wakasawa T; Funabashi M; Fukushi A; Fujita M; Motojima K; Tamai I
    Biol Pharm Bull; 2008 Jun; 31(6):1230-6. PubMed ID: 18520060
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression.
    Watanabe C; Kato Y; Sugiura T; Kubo Y; Wakayama T; Iseki S; Tsuji A
    Drug Metab Dispos; 2006 Nov; 34(11):1927-34. PubMed ID: 16896066
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis, transport and mechanism of a type I prodrug: L-carnitine ester of prednisolone.
    Mo JX; Shi SJ; Zhang Q; Gong T; Sun X; Zhang ZR
    Mol Pharm; 2011 Oct; 8(5):1629-40. PubMed ID: 21854030
    [TBL] [Abstract][Full Text] [Related]  

  • 66. OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1).
    Glube N; Closs E; Langguth P
    Mol Pharm; 2007; 4(1):160-8. PubMed ID: 17274673
    [TBL] [Abstract][Full Text] [Related]  

  • 67. OCTN2VT, a splice variant of OCTN2, does not transport carnitine because of the retention in the endoplasmic reticulum caused by insertion of 24 amino acids in the first extracellular loop of OCTN2.
    Maekawa S; Mori D; Nishiya T; Takikawa O; Horinouchi T; Nishimoto A; Kajita E; Miwa S
    Biochim Biophys Acta; 2007 Jun; 1773(6):1000-6. PubMed ID: 17509700
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In-cell Western™ detection of organic cation transporters in bronchial epithelial cell layers cultured at an air-liquid interface on Transwell(®) inserts.
    Mukherjee M; Latif ML; Pritchard DI; Bosquillon C
    J Pharmacol Toxicol Methods; 2013; 68(2):184-189. PubMed ID: 23764373
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells.
    Kobayashi D; Irokawa M; Maeda T; Tsuji A; Tamai I
    Reproduction; 2005 Dec; 130(6):931-7. PubMed ID: 16322553
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2.
    Wagner CA; Lükewille U; Kaltenbach S; Moschen I; Bröer A; Risler T; Bröer S; Lang F
    Am J Physiol Renal Physiol; 2000 Sep; 279(3):F584-91. PubMed ID: 10966938
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier.
    Kido Y; Tamai I; Ohnari A; Sai Y; Kagami T; Nezu J; Nikaido H; Hashimoto N; Asano M; Tsuji A
    J Neurochem; 2001 Dec; 79(5):959-69. PubMed ID: 11739607
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Organic cation transporters (OCTs/OCTNs) in human primary alveolar epithelial cells.
    Barilli A; Visigalli R; Ferrari F; Di Lascia M; Riccardi B; Puccini P; Dall'Asta V; Rotoli BM
    Biochem Biophys Res Commun; 2021 Oct; 576():27-32. PubMed ID: 34478916
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Absorption of ipratropium and l-carnitine into the pulmonary circulation of the ex-vivo rat lung is driven by passive processes rather than active uptake by OCT/OCTN transporters.
    Al-Jayyoussi G; Price DF; Kreitmeyr K; Keogh JP; Smith MW; Gumbleton M; Morris CJ
    Int J Pharm; 2015 Dec; 496(2):834-41. PubMed ID: 26475971
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Selective inhibition of OCTN2 is more effective than inhibition of gamma-butyrobetaine dioxygenase to decrease the availability of l-carnitine and to reduce myocardial infarct size.
    Liepinsh E; Makrecka M; Kuka J; Cirule H; Makarova E; Sevostjanovs E; Grinberga S; Vilskersts R; Lola D; Loza E; Stonans I; Pugovics O; Dambrova M
    Pharmacol Res; 2014 Jul; 85():33-8. PubMed ID: 24836867
    [TBL] [Abstract][Full Text] [Related]  

  • 75. OCTN2 is associated with carnitine transport capacity of rat skeletal muscles.
    Furuichi Y; Sugiura T; Kato Y; Shimada Y; Masuda K
    Acta Physiol (Oxf); 2010 Sep; 200(1):57-64. PubMed ID: 20219053
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The pro-inflammatory cytokine tumor necrosis factor α stimulates expression of the carnitine transporter OCTN2 (novel organic cation transporter 2) and carnitine uptake via nuclear factor-κB in Madin-Darby bovine kidney cells.
    Zhou X; Ringseis R; Wen G; Eder K
    J Dairy Sci; 2015 Jun; 98(6):3840-8. PubMed ID: 25892691
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacological rescue of carnitine transport in primary carnitine deficiency.
    Amat di San Filippo C; Pasquali M; Longo N
    Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies.
    Macdonald C; Shao D; Oli A; Agu RU
    J Drug Target; 2013 Jan; 21(1):97-106. PubMed ID: 23050869
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Discovery of Highly Potent THP Derivatives as OCTN2 Inhibitors: From Structure-Based Virtual Screening to In Vivo Biological Activity.
    Di Cristo F; Calarco A; Digilio FA; Sinicropi MS; Rosano C; Galderisi U; Melone MAB; Saturnino C; Peluso G
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050117
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of two novel mutations in OCTN2 from two Saudi patients with systemic carnitine deficiency.
    Rahbeeni Z; Vaz FM; Al-Hussein K; Bucknall MP; Ruiter J; Wanders RJ; Rashed MS
    J Inherit Metab Dis; 2002 Sep; 25(5):363-9. PubMed ID: 12408185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.